• UTMB Awarded a $15.6 Million/year NIH Grant for Three Years of Vaccine Development with Partners

    The University of Texas Medical Branch recently received a three-year award of $15.6 million per year from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) to conduct cutting-edge research aimed at developing vaccines and monoclonal antibodies (mAbs) to combat high-priority viral pathogens.

  • Texas City ISD filters drinking water after finding traces of lead

    “Lead can cause effects on all organs throughout the body: skin, blood, bone, nervous system, kidneys, heart and lungs. Really any organ can be poisoned by lead,” UTMB’s Dr. Mark Winter tells the Daily News after small traces of lead contamination were found at a Texas City ISD water fountain.

  • NASA’s SpaceX Crew-9 to Conduct Space Station Research

    Some astronauts experience vision changes while in space, a condition called Spaceflight-Associated Neuro-ocular Syndrome. “We still do not know exactly what causes this syndrome, and not everyone gets it,” said UTMB’s Dr. Sara Zwart but her research study, which is making its way to the International Space Station, will test whether a daily B vitamin supplement can prevent or mitigate the problem.

  • Some moms in addiction recovery say they were discouraged from breastfeeding

    “All of the wonderful qualities of human milk, particularly mother’s own milk, is just incredibly beneficial for these newborns,” UTMB’s Dr. Lisa Cleveland tells radio station WVTF. While not all medical providers are up to date on the latest recommendations, it is safe for mothers to breast feed their babies when they are in medically assisted treatment for addiction.

  • Where your morning coffee came from

    Drs. Norbert Herzog and David Niesel discuss the origins of coffee in their latest Medical Discovery News column.

  • New drug class could reverse age-related muscle weakness

    Dr. Stan Watowich penned a piece for The Academic about NNMT inhibitors, a new class of drugs that could change how people age. “Imagine a world where ageing doesn’t mean losing strength but gaining a new lease on life,” Watowich writes. “That’s the promise of NNMT inhibitors, and it’s an exciting future that could soon become a reality.”

  • New mpox strain fuels deadlier resurgence

    A more severe variant of the monkeypox virus is driving the 2024 mpox outbreak, write Drs. Megan Berman and Richard Rupp for this week’s Vaccine Smarts column. The good news is that effective vaccines are available, they write.

Categories